Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets

Drug Development and Industrial Pharmacy

Volumn 35, Issue 10, 2009, Pages 1264-1270

  Zugasti, Maria Esther ^a   Zornoza, Arantza ^a   Del Mar Goi, Mara ^a   Isasi, Jos Ramn ^a   Vlaz, Itziar ^a   Martn, Carmen ^a   Snchez, Miguel ^a   Martnez Ohrriz, Mara Cristina ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cyclodextrin; Drug release; HPMC; Solid state; Soluble and insoluble cyclodextrin polymers

Indexed keywords

BETA CYCLODEXTRIN; DIFLUNISAL; HYDROXYPROPYLMETHYLCELLULOSE;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; POLYMERIZATION; X RAY DIFFRACTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DIFFERENTIAL THERMAL ANALYSIS; DIFLUNISAL; DRUG CARRIERS; EXCIPIENTS; KINETICS; METHYLCELLULOSE; SOLUBILITY; SPECTROPHOTOMETRY, INFRARED; TABLETS; X-RAY DIFFRACTION;

EID: 70350690701     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902882306     Document Type: Article

References (32)

1. Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139-157
2. Fu XC, Wang GP, Liang WQ, Chow MSS. (2004). Prediction of drug release from HPMC matrices: Effect of physicochemical properties of drug and polymer concentration. J Control Release, 95:209-216
3. Conti S, Maggi L, Segale L, Ochoa Machiste E, Conte U, Grenier P, et al. (2007). Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int J Pharm, 333:136-142 (Pubitemid 46283280)
4. Bettini R, Catellani PL, Santi P, Massimo G, Peppas NA, Colombo P. (2001). Translocation of drug particles in HPMC matrix gel layer: Effect of drug solubility and influence on release rate. J Control Release, 70:383-391
5. Siepmann J, Streubel A, Peppas NA. (2002). Understanding and predicting drug delivery from hydrophilic matrix tablets using the 'sequential layer' model. Pharm Res, 19:306-314
6. Miranda A, Millán M, Caraballo I. (2006). Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery. Int J Pharm, 311:75-81.
7. Levina M, Rajabi-Siahboomi AR. (2004). The influence of excipients on drug release from hydroxypropyl methylcellulose matrices. J Pharm Sci, 93:2746-2754
8. Bibby DC, Davies NM, Tucker IG. (2000). Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm, 197:1-11.
9. Szejtli J, Osa T. (1996). Cyclodextrins, comprehensive supramolecular chemistry, vol.3. Oxford (UK): Pergamon.
10. Loftsson T, Duchêne D. (2007). Cyclodextrins and their pharmaceutical applications. Int J Pharm, 329:1-11.
11. Pose-Vilarnovo B, Rodríguez-Tenreiro C, Rosa dos Santos JF, Vázquez-Doval J, Concheiro A, Alvarez-Lorenzo C. (2004). Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. J Control Release, 94:351-363
12. Koester LS, Clarissa RX, Mayorga P, Bassani VL. (2003). Influence of ?-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets. Eur J Pharm Biopharm, 55:85-91.
13. Sangalli ME, Zema L, Maroni A, Foppoli A, Giordano F, Gazzaniga A. (2001). Influence of betacyclodextrin on the release of poorly soluble drugs from inert and hydrophilic heterogeneous polymeric matrices. Biomaterials, 22:2647-2651
14. Koester LS, Ortega GG, Mayorga P, Bassani VL. (2004). Mathematical evaluation of in vitro release profiles of hydroxypropylmethylcellulose matrix tablets containing carbamazepine associated to ?-cyclodextrin. Eur J Pharm Biopharm, 58:177-179
15. Ribeiro L, Ferreira DC, Veiga FJB. (2005). In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets. J Control Release, 103:325-339
16. Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME. (2005). Role of cellulose ether polymers on ibuprofen release from matrix tablets. Drug Dev Ind Pharm, 31:653-665
17. Liu YY, Fan XD, Kang T, Sun L. (2004). A cyclodextrin microgel for controlled release driven by inclusion effects. Macromol Rapid Commun, 25:1912-1916
18. Li J, Xiao H, Li J, Zhong YP. (2004). Drug carrier systems based on water-soluble cationic ?-cyclodextrin polymers. Int J Pharm, 278:329-342
19. Rodriguez-Tenreiro C, Alvarez-Lorenzo C, Rodriguez-Perez A, Concheiro A, Torres-Labandeira JJ. (2006). New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability. Pharm Res, 23:121-130
20. Rodriguez-Tenreiro C, Alvarez-Lorenzo C, Rodriguez-Perez A, Concheiro A, Torres-Labandeira JJ. (2007). Estradiol sustained release from high affinity cyclodextrin hydrogels. Eur J Pharm Biopharm, 66:55-62.
21. Zornoza A, Sánchez M, Vélaz I, Fernandez L. (1999). Diflunisal and its complexation with cyclodextrins. A fluorimetric study. Biomed Chromatogr, 13:111-112
22. García-Zubiri IX, González-Gaitano G, Isasi JR. (2007). Isosteric heats of sorption of 1-naphthol and phenol from aqueous solutions by cyclodextrin polymers. J Colloid Interface Sci, 307:64-70.
23. Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123-133
24. Costa FO, Sousa JJS, Pais AACC, Formosinho SJ. (2003). Comparison of dissolution profiles of ibuprofen pellets. J Control Release, 89:199-212.
25. Martínez-Ohárriz MC, Martín C, Goñi MM, Rodríguez-Espinosa C, Tros de Ilarduya-Apaolaza MC, Sánchez M. (1994). Polymorphism of diflunisal: Isolation and characteristics of a new crystal form. J Pharm Sci, 83:174-177
26. Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. (1999). Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release, 57:75-85.
27. Moore JW, Flanner HH. (1996). Mathematical comparison of dissolution profiles. Pharm Tech, 20:64-74.
28. FDA. (1977). Guidance for industry: Dissolution testing of immediate release solid oral dosage forms. Rockville (MD): FDA Center for Drug Evaluation and Research. http://www.fda.gov/cder/guidance.htm [accessed August 25, 1997].
29. Cotton M, Hux R. (1985). Diflunisal. In: Florey K, ed. Analytical profiles of drug substances. London: Academic Press, Inc., 491-526.
30. Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110-111
31. Ferrero C, Muñoz-Ruiz A, Jiménez-Castellanos MR. (1985). Fronts movement as a useful tool for hydrophilic matrix release mechanism elucidation. Int J Pharm, 202:21-28
32. Gazpio C, Sánchez M, Isasi JR, Vélaz I, Martín C, Martínez-Ohárriz C, Zornoza A. (2008). Sorption of pindolol and related compounds by a beta-cyclodextrin polymer. Isosteric heat of sorption. Carbohydr Polym, 71:140-146